Intended for healthcare professionals

Letters Bisphosphonates for osteoporosis

Risk of atrial fibrillation with bisphosphonate treatment

BMJ 2015; 351 doi: (Published 04 November 2015) Cite this as: BMJ 2015;351:h5870
  1. Shahid A Kausar, consultant physician1
  1. 1Department of Stroke Medicine, Russells Hall Hospital, Dudley DY1 2HQ, UK
  1. shahid.kausar{at}

Maraka and Kennel discussed the adverse effects associated with bisphosphonate treatment in detail but failed to mention the risk of atrial fibrillation.1 2

The risk of new onset atrial fibrillation is increased by the use of both oral and intravenous bisphosphonates, although the risk may be greater with …

View Full Text

Log in

Log in through your institution


* For online subscription